ANTIBODIES
The invention relates to antibodies or antigen-binding fragments thereof which specifically bind to CXCR4. The invention also relates to said antibodies for use in therapy, for use in treating cancer, and for use in treating a solid tumor. The invention also relates to pharmaceutical compositions co...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | BENNETT, Kirstie STOTT, Lisa BILLAUD, Margot ROWLANDS, Robert LECOINTRE, Morgane Marie WAKE, Matthew Stephen MCCOURT, John Matthew BARNES, Matthew HUTCHINGS, Catherine |
| description | The invention relates to antibodies or antigen-binding fragments thereof which specifically bind to CXCR4. The invention also relates to said antibodies for use in therapy, for use in treating cancer, and for use in treating a solid tumor. The invention also relates to pharmaceutical compositions comprising said antibodies, nucleic acids that encode said antibodies, vectors comprising said nucleic acids, and host cells comprising said nucleic acids or vectors.
L'invention concerne des anticorps ou des fragments de liaison à l'antigène de ceux-ci qui se lient spécifiquement à CXCR4. L'invention concerne également lesdits anticorps destinés à être utilisés en thérapie, dans le traitement du cancer et dans le traitement d'une tumeur solide. L'invention concerne en outre des compositions pharmaceutiques comprenant lesdits anticorps, des acides nucléiques qui codent lesdits anticorps, des vecteurs comprenant lesdits acides nucléiques et des cellules hôtes comprenant lesdits acides nucléiques ou vecteurs. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2024160721A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2024160721A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2024160721A13</originalsourceid><addsrcrecordid>eNrjZOBy9AvxdPJ38XQN5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgZGJoZmBuZGho6GxsSpAgDHQRy1</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTIBODIES</title><source>esp@cenet</source><creator>BENNETT, Kirstie ; STOTT, Lisa ; BILLAUD, Margot ; ROWLANDS, Robert ; LECOINTRE, Morgane Marie ; WAKE, Matthew Stephen ; MCCOURT, John Matthew ; BARNES, Matthew ; HUTCHINGS, Catherine</creator><creatorcontrib>BENNETT, Kirstie ; STOTT, Lisa ; BILLAUD, Margot ; ROWLANDS, Robert ; LECOINTRE, Morgane Marie ; WAKE, Matthew Stephen ; MCCOURT, John Matthew ; BARNES, Matthew ; HUTCHINGS, Catherine</creatorcontrib><description>The invention relates to antibodies or antigen-binding fragments thereof which specifically bind to CXCR4. The invention also relates to said antibodies for use in therapy, for use in treating cancer, and for use in treating a solid tumor. The invention also relates to pharmaceutical compositions comprising said antibodies, nucleic acids that encode said antibodies, vectors comprising said nucleic acids, and host cells comprising said nucleic acids or vectors.
L'invention concerne des anticorps ou des fragments de liaison à l'antigène de ceux-ci qui se lient spécifiquement à CXCR4. L'invention concerne également lesdits anticorps destinés à être utilisés en thérapie, dans le traitement du cancer et dans le traitement d'une tumeur solide. L'invention concerne en outre des compositions pharmaceutiques comprenant lesdits anticorps, des acides nucléiques qui codent lesdits anticorps, des vecteurs comprenant lesdits acides nucléiques et des cellules hôtes comprenant lesdits acides nucléiques ou vecteurs.</description><language>eng ; fre</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240808&DB=EPODOC&CC=WO&NR=2024160721A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240808&DB=EPODOC&CC=WO&NR=2024160721A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BENNETT, Kirstie</creatorcontrib><creatorcontrib>STOTT, Lisa</creatorcontrib><creatorcontrib>BILLAUD, Margot</creatorcontrib><creatorcontrib>ROWLANDS, Robert</creatorcontrib><creatorcontrib>LECOINTRE, Morgane Marie</creatorcontrib><creatorcontrib>WAKE, Matthew Stephen</creatorcontrib><creatorcontrib>MCCOURT, John Matthew</creatorcontrib><creatorcontrib>BARNES, Matthew</creatorcontrib><creatorcontrib>HUTCHINGS, Catherine</creatorcontrib><title>ANTIBODIES</title><description>The invention relates to antibodies or antigen-binding fragments thereof which specifically bind to CXCR4. The invention also relates to said antibodies for use in therapy, for use in treating cancer, and for use in treating a solid tumor. The invention also relates to pharmaceutical compositions comprising said antibodies, nucleic acids that encode said antibodies, vectors comprising said nucleic acids, and host cells comprising said nucleic acids or vectors.
L'invention concerne des anticorps ou des fragments de liaison à l'antigène de ceux-ci qui se lient spécifiquement à CXCR4. L'invention concerne également lesdits anticorps destinés à être utilisés en thérapie, dans le traitement du cancer et dans le traitement d'une tumeur solide. L'invention concerne en outre des compositions pharmaceutiques comprenant lesdits anticorps, des acides nucléiques qui codent lesdits anticorps, des vecteurs comprenant lesdits acides nucléiques et des cellules hôtes comprenant lesdits acides nucléiques ou vecteurs.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZOBy9AvxdPJ38XQN5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgZGJoZmBuZGho6GxsSpAgDHQRy1</recordid><startdate>20240808</startdate><enddate>20240808</enddate><creator>BENNETT, Kirstie</creator><creator>STOTT, Lisa</creator><creator>BILLAUD, Margot</creator><creator>ROWLANDS, Robert</creator><creator>LECOINTRE, Morgane Marie</creator><creator>WAKE, Matthew Stephen</creator><creator>MCCOURT, John Matthew</creator><creator>BARNES, Matthew</creator><creator>HUTCHINGS, Catherine</creator><scope>EVB</scope></search><sort><creationdate>20240808</creationdate><title>ANTIBODIES</title><author>BENNETT, Kirstie ; STOTT, Lisa ; BILLAUD, Margot ; ROWLANDS, Robert ; LECOINTRE, Morgane Marie ; WAKE, Matthew Stephen ; MCCOURT, John Matthew ; BARNES, Matthew ; HUTCHINGS, Catherine</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2024160721A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>BENNETT, Kirstie</creatorcontrib><creatorcontrib>STOTT, Lisa</creatorcontrib><creatorcontrib>BILLAUD, Margot</creatorcontrib><creatorcontrib>ROWLANDS, Robert</creatorcontrib><creatorcontrib>LECOINTRE, Morgane Marie</creatorcontrib><creatorcontrib>WAKE, Matthew Stephen</creatorcontrib><creatorcontrib>MCCOURT, John Matthew</creatorcontrib><creatorcontrib>BARNES, Matthew</creatorcontrib><creatorcontrib>HUTCHINGS, Catherine</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BENNETT, Kirstie</au><au>STOTT, Lisa</au><au>BILLAUD, Margot</au><au>ROWLANDS, Robert</au><au>LECOINTRE, Morgane Marie</au><au>WAKE, Matthew Stephen</au><au>MCCOURT, John Matthew</au><au>BARNES, Matthew</au><au>HUTCHINGS, Catherine</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTIBODIES</title><date>2024-08-08</date><risdate>2024</risdate><abstract>The invention relates to antibodies or antigen-binding fragments thereof which specifically bind to CXCR4. The invention also relates to said antibodies for use in therapy, for use in treating cancer, and for use in treating a solid tumor. The invention also relates to pharmaceutical compositions comprising said antibodies, nucleic acids that encode said antibodies, vectors comprising said nucleic acids, and host cells comprising said nucleic acids or vectors.
L'invention concerne des anticorps ou des fragments de liaison à l'antigène de ceux-ci qui se lient spécifiquement à CXCR4. L'invention concerne également lesdits anticorps destinés à être utilisés en thérapie, dans le traitement du cancer et dans le traitement d'une tumeur solide. L'invention concerne en outre des compositions pharmaceutiques comprenant lesdits anticorps, des acides nucléiques qui codent lesdits anticorps, des vecteurs comprenant lesdits acides nucléiques et des cellules hôtes comprenant lesdits acides nucléiques ou vecteurs.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2024160721A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | ANTIBODIES |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T12%3A58%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BENNETT,%20Kirstie&rft.date=2024-08-08&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2024160721A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |